Literature DB >> 34712466

Provision of care for pregnant women with IBD in the UK: the current landscape.

Sarah Wolloff1, Emma Moore1, Tracey Glanville2, Jimmy Limdi3,4, Klaartje B Kok5, Aileen Fraser6, Alexandra Kent7, Khasia Mulgabal8, Catherine Nelson-Piercy9, Christian Selinger1.   

Abstract

INTRODUCTION: Suboptimal control of inflammatory bowel disease (IBD) can result in increased rates of adverse pregnancy-related outcomes. We aimed to describe the current landscape of provision of antenatal care for women with IBD in the UK.
METHODS: This cross-sectional survey collected data on service setup; principles of care pre-conception, during pregnancy and post partum; and on perceived roles and responsibilities of relevant clinicians.
RESULTS: Data were provided for 97 IBD units. Prepregnancy counselling was offered mostly on request only (54%) and in an ad hoc manner. In 86% of units, IBD antenatal care was provided by the patient's usual gastroenterologist, rather than a gastroenterologist with expertise in pregnancy (14%). Combined clinics with obstetricians and gastroenterologists were offered in 14% of units (24% academic vs 7% district hospitals; p=0.043). Communication with obstetrics was 'as and when required' in 51% and 30% of IBD units reviewed pregnant women with IBD 'only when required'. The majority of respondents thought gastroenterologists should be involved in decisions regarding routine vaccinations (70%), breast feeding (80%), folic acid dosage (61%) and venous thromboembolism (VTE) prophylaxis (53%). Sixty-five per cent of respondents thought that gastroenterologists should be involved in decisions around mode of delivery and 30% recommended caesarean sections for previous but healed perianal disease.
CONCLUSIONS: This nationwide survey found considerable variation in IBD antenatal services. We identified deficiencies in service setup, care provided by IBD units and clinician knowledge. A basic framework to inform service setup, and better education on the available clinical guidance, is required to ensure consistent high-quality multidisciplinary care. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Crohn's disease; ulcerative colitis

Year:  2020        PMID: 34712466      PMCID: PMC8515275          DOI: 10.1136/flgastro-2020-101546

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  22 in total

Review 1.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.

Authors:  Natalie A Molodecky; Ing Shian Soon; Doreen M Rabi; William A Ghali; Mollie Ferris; Greg Chernoff; Eric I Benchimol; Remo Panaccione; Subrata Ghosh; Herman W Barkema; Gilaad G Kaplan
Journal:  Gastroenterology       Date:  2011-10-14       Impact factor: 22.682

2.  What is the peak age for onset of IBD?

Authors:  Richard D Johnston; Richard F A Logan
Journal:  Inflamm Bowel Dis       Date:  2008-10       Impact factor: 5.325

3.  Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group.

Authors:  Uma Mahadevan; Christopher Robinson; Nana Bernasko; Brigid Boland; Christina Chambers; Marla Dubinsky; Sonia Friedman; Sunanda Kane; Jacob Manthey; Jason Sauberan; Joanne Stone; Rajeev Jain
Journal:  Gastroenterology       Date:  2019-01-16       Impact factor: 22.682

4.  Letter: pregnant women with IBD are more likely to be adherent to biologic therapies than other medications.

Authors:  Robyn Laube; Christian P Selinger
Journal:  Aliment Pharmacol Ther       Date:  2020-05       Impact factor: 8.171

5.  What Factors Might Drive Voluntary Childlessness (VC) in Women with IBD? Does IBD-specific Pregnancy-related Knowledge Matter?

Authors:  Christian P Selinger; Jihane Ghorayeb; Anna Madill
Journal:  J Crohns Colitis       Date:  2016-03-17       Impact factor: 9.071

6.  Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey.

Authors:  Míriam Mañosa; Mercè Navarro-Llavat; Laura Marín; Yamile Zabana; Eduard Cabré; Eugeni Domènech
Journal:  Scand J Gastroenterol       Date:  2013-03-11       Impact factor: 2.423

7.  Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications.

Authors:  Sangmin Lee; Cynthia H Seow; Kamala Adhikari; Amy Metcalfe
Journal:  Aliment Pharmacol Ther       Date:  2019-12-02       Impact factor: 8.171

8.  Preconception Care Reduces Relapse of Inflammatory Bowel Disease During Pregnancy.

Authors:  Alison de Lima; Zuzana Zelinkova; Annemarie G M G J Mulders; C Janneke van der Woude
Journal:  Clin Gastroenterol Hepatol       Date:  2016-03-18       Impact factor: 11.382

9.  Pregnancy intentions, maternal behaviors, and infant health: investigating relationships with new measures and propensity score analysis.

Authors:  Kathryn Kost; Laura Lindberg
Journal:  Demography       Date:  2015-02

10.  Decreased fertility rates in 9639 women diagnosed with inflammatory bowel disease: a United Kingdom population-based cohort study.

Authors:  L Ban; L J Tata; D J Humes; L Fiaschi; T Card
Journal:  Aliment Pharmacol Ther       Date:  2015-08-06       Impact factor: 9.524

View more
  1 in total

1.  Twitter debate: controversies in pregnancy in IBD and liver disease.

Authors:  Aditi Kumar; Catherine Nelson-Piercy; Christian Selinger
Journal:  Frontline Gastroenterol       Date:  2021-09-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.